🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Intuitive surgical exec sells over $200k in company stock

Published 05/15/2024, 05:42 PM
ISRG
-

Intuitive Surgical Inc (NASDAQ:ISRG) executive Brosius Mark, who serves as the company's Senior Vice President & Chief Manufacturing and Supply Chain Officer, has recently sold a total of $202,515 worth of company stock. The transactions occurred over a series of three days, with the executive selling shares at prices ranging from $380.85 to $389.16.

The sales were executed in accordance with a pre-established Trading Plan that is in compliance with SEC Rule 10b5-1, which allows company insiders to set up a trading plan for selling stocks they own. This plan is set to expire on June 7, 2024. It is a common practice for executives to sell shares in a structured manner to avoid concerns about insider trading.

On May 13, 2024, Brosius sold 175 shares of Intuitive Surgical stock at $389.16 per share. The following day, another 175 shares were sold at a slightly lower price of $380.85 each. The final sale took place on May 15, with an additional 175 shares sold at $387.22 per share. After these transactions, Brosius still held 533 shares of the company's common stock.

Investors often monitor insider sales as they can provide insights into an executive's view of the company's current valuation and future prospects. However, such sales can also be part of personal financial planning and diversification strategies and do not necessarily indicate a lack of confidence in the company.

Intuitive Surgical Inc, which specializes in orthopedic, prosthetic, and surgical appliances and supplies, is known for its da Vinci surgical systems, a technology that enables minimally invasive surgery with robotic assistance. The company's shares are traded on the NASDAQ under the ticker symbol ISRG.

InvestingPro Insights

Intuitive Surgical Inc (NASDAQ:ISRG) has been in the spotlight following the recent stock sales by executive Brosius Mark. As investors seek to understand the implications of these sales, it's worth considering the company's financial metrics and market performance. According to InvestingPro data, Intuitive Surgical boasts a robust market capitalization of $141.67 billion, reflective of its leading position in the medical technology sector.

The company's P/E ratio stands at 70.52, indicating a high earnings multiple that suggests investors are expecting high future earnings growth. This aligns with the InvestingPro Tips, which highlight that Intuitive Surgical is trading at a high P/E ratio relative to near-term earnings growth. Additionally, the company's revenue has grown by 13.81% over the last twelve months as of Q1 2024, demonstrating its continued expansion in the market.

InvestingPro Tips also reveal that Intuitive Surgical's stock generally trades with low price volatility, which could be an attractive feature for investors seeking stability in their portfolio. Moreover, the company's liquid assets exceed its short-term obligations, providing financial flexibility and a buffer against market downturns.

For investors interested in a deeper dive into Intuitive Surgical's financials and stock performance, InvestingPro offers additional insights. There are 15 more InvestingPro Tips available for ISRG, which can be accessed at InvestingPro's dedicated page for the company. Readers looking to take advantage of these insights can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, enhancing their investment research with valuable expert analysis.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.